David Tyronne Howton, Jr
2017
In 2017, David Tyronne Howton, Jr earned a total compensation of $1.8M as Senior Vice President, General Counsel and Corporate Secretary at Sarepta Therapeutics, a 22% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $228,019 |
|---|---|
| Option Awards | $481,146 |
| Salary | $407,176 |
| Stock Awards | $694,269 |
| Other | $12,918 |
| Total | $1,823,528 |
Howton received $694.3K in stock awards, accounting for 38% of the total pay in 2017.
Howton also received $228K in non-equity incentive plan, $481.1K in option awards, $407.2K in salary and $12.9K in other compensation.
Rankings
In 2017, David Tyronne Howton, Jr's compensation ranked 5,955th out of 14,666 executives tracked by ExecPay. In other words, Howton earned more than 59.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,955 out of 14,666 | 59th |
Division Manufacturing | 2,178 out of 5,772 | 62nd |
Major group Chemicals And Allied Products | 679 out of 2,075 | 67th |
Industry group Drugs | 526 out of 1,731 | 70th |
Industry Pharmaceutical Preparations | 417 out of 1,333 | 69th |
Source: SEC filing on April 26, 2018.
Howton's colleagues
We found six more compensation records of executives who worked with David Tyronne Howton, Jr at Sarepta Therapeutics in 2017.
2017
Douglas Ingram
Sarepta Therapeutics
Chief Executive Officer
2017
Edward Kaye
Sarepta Therapeutics
Chief Executive Officer
2017
Guriqbal Basi
Sarepta Therapeutics
Chief Scientific Officer
2017
Alexander Cumbo
Sarepta Therapeutics
Senior Vice President, Chief Commercial Officer
2017
Sandesh Mahatme
Sarepta Therapeutics
Chief Financial Officer
2017
Catherine Stehman-Breen
Sarepta Therapeutics